| ¿µ¹® | symptomatic therapy | ÇÑ±Û | ´ëÁõ¿ä¹ý |
|---|---|---|---|
| ¼³¸í | º´ÀÇ ¿øÀÎÀ» ã¾Æ ¾ø¾Ö±â °ï¶õÇÑ »óȲ¿¡¼, °ÑÀ¸·Î ³ªÅ¸³ º´ÀÇ Áõ»ó¿¡ ´ëÀÀÇÏ¿© óġ¸¦ ÇÏ´Â Ä¡·á¹ý. ¿ÀÌ ³ôÀ» ¶§¿¡ ¾óÀ½ÁָӴϸ¦ ´ë°Å³ª ÇØ¿Á¦¸¦ ½á¼ ¿À» ³»¸®°Ô ÇÏ´Â µûÀ§°¡ ÀÌ¿¡ ¼ÓÇÑ´Ù. |
||
| ¿µ¹® | radiation therapy | ÇÑ±Û | ¹æ»ç¼±¿ä¹ý |
|---|---|---|---|
| ¼³¸í | X¼±, ¥ã¼±ÀÇ ÀüÀÚ¹æ»ç¼±À̳ª ÀüÀÚ¼±, ¾çÀÚ¼±, Áß¼ºÀÚ¼± µîÀÇ ÀÔÀÚ¹æ»ç¼±À» ÀÌ¿ëÇØ, ÁÖ·Î ¾Ç¼º Á¾¾ç Ä¡·á¸¦ ¸ñÀûÀ¸·Î ÇÏ´Â Ä¡·á¹ýÀÌ´Ù. ¾Ï¼¼Æ÷°¡ ÁÖÀ§ÀÇ Á¤»ó¼¼Æ÷º¸´Ùµµ ¹æ»ç¼± °¨¼ö¼ºÀÌ ³ôÀº Á¡À» ÀÌ¿ëÇÏ¿©, Á¤»ó¼¼Æ÷ÀÇ ¼Õ»óÀ» °¡´ÉÇÑ ÇÑ ÃÖ¼Ò·Î ¾ïÁ¦ÇÏ¸é¼ ¾Ï¼¼Æ÷¸¦ ÆÄ±«ÇÑ´Ù. »ç¿ëµÇ´Â ¹æ»ç¼±¿¡´Â ¹ÐºÀ¼Ò¼±¿ø¿¡¼ ³ª¿À´Â ¥ã¼±, Á÷¼±°¡¼Ó±â¿¡¼ ¾ò¾îÁö´Â °í¿¡³ÊÁö X¼±°ú ÀüÀÚ¼±, ÅÚ·¹ÄÚ¹ßÆ®ÀåÄ¡¿¡ ÀÇÇÑ 60CoÀÇ ¥ã¼±°ú, º£Å¸Æ®·Ð¿¡ ÀÇÇÑ ÀüÀÚ¼±, »çÀÌÅ©·ÎÆ®·Ð¿¡¼ ¾ò¾îÁö´Â ¾çÀÚ¼±, Áß¼ºÀÚ¼± µîÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | radiation therapy | ÇÑ±Û | ¹æ»ç¼±Ä¡·á |
|---|---|---|---|
| ¼³¸í | ¹æ»ç¼±ÀÇ »ì±ÕÈ¿°ú³ª ¼¼Æ÷¸¦ Á×ÀÌ´Â È¿°ú¸¦ Ä¡·á¿¡ ÀÌ¿ëÇÏ´Â ¹æ¹ýÀ¸·Î, Á¼Àº Àǹ̷Π¾ÏÀÇ ¹æ»ç¼±Ä¡·á¸¦ ÀǹÌÇÑ´Ù. ¾Ï¿¡ ´ëÇÑ ¹æ»ç¼±Ä¡·á´Â ¾Ï¼¼Æ÷¸¦ Á×À̴µ¥ È¿°ú°¡ Å« º£Å¸¼±À» ÁÖ·Î »ç¿ëÇÑ´Ù. ÇÏÁö¸¸, ÀÌ·± ¹æ»ç¼±Ä¡·á´Â Á¤»ó¼¼Æ÷¿¡µµ Å« ¿µÇâÀ» ³¢ÃÄ ÀÌ¿¡ µû¸¥ ±â´ÉÀÇ Àå¾Ö¸¦ °¡Á®¿Ã ¼ö ÀÖ´Ù. µû¶ó¼ ¹æ»ç¼±Ä¡·á¿¡ À־ ´ÜÁö ±× ¾Ï¼¼Æ÷¿¡ ´ëÇÑ ÀÛ¿ë»Ó¸¸ ¾Æ´Ï¶ó, Á¤»ó¼¼Æ÷¿¡ ´ëÇÑ ÀÛ¿ëµµ °í·ÁÇÏ¿© ½ÃÇàÇÑ´Ù. |
||
| ¿µ¹® | speech therapy | ÇÑ±Û | ¾ð¾îÄ¡·á |
|---|---|---|---|
| ¼³¸í | ¸»À» Á¤È®ÇÏ°Ô ¹ßÀ½ÇÒ ¼ö ¾ø°Å³ª ´õµë´Â ȯÀÚ¿¡°Ô ¹ßÀ½, ´ëÈ µûÀ§ÀÇ ÈÆ·ÃÀ» Àü¹®ÀûÀ¸·Î ÇàÇÏ´Â Ä¡·á¹ý. |
||
| ¿µ¹® | therapy | ÇÑ±Û | ¿ä¹ý |
|---|---|---|---|
| ¼³¸í | º´À» ³´°Ô ÇÏ´Â °Í ¶Ç´Â ±× ¹æ¹ý. |
||
| GT | gait training; galactosyl transferase; gastrostomy; generation time; genetic therapy; gingiva treatm... |
|---|---|
| RT | radiologic technologist; radiotelemetry; radiotherapy; radium therapy; rapid tranquilization; reacti... |
| SC | conditioned stimulus; sacrococcygeal; Sanitary Corps; scalenus [muscle]; scapula; Schwann cell; scia... |
| CBF | capillary blood flow; cerebral blood flow; ciliary beat frequency; coronary blood flow; cortical blo... |
| HBF | hand blood flow; hemispheric blood flow; hemoglobinuric bilious fever; hepatic blood flow; hypothala... |
| secretory component of IgA | <immunology, protein> A polypeptide chain of about 60 kD that aids secretion of the IgA, a portion of the IgA receptor on the plasmalemma of the inner side of the epithelial cells lining the gut, which is proteolysed when the IgA receptor complex has travelled through the cell after receptor mediated endocytosis at the inner face, to the outer (luminal) face. (18 Nov 1997) |
|---|---|
| serum amyloid P component | Precursor of amyloid component P, found in basement membrane. Member of the pentraxin family. See: serum amyloid. (18 Nov 1997) |
| two-component plasma | <radiobiology> Refers to a plasma containing a cool thermal component and a population of high energy particles (such as from neutral beam injection) which are in the process of thermalising (slowing down). (09 Oct 1997) |
| fast component | <molecular biology> A segment of eukaryotic DNA consisting of highly-repeated nucleotide sequences which, when the entire duplex DNA molecule is denatured (the double-stranded helix comes apart and becomes single strands) and then allowed to renature (the complementary single strands come together to form a helix), will be the first segment to renature. (09 Oct 1997) |
| acupuncture therapy | Treatment of disease by inserting needles along specific pathways or meridians. The placement varies with the disease being treated. Heat or moxibustion and acupressure may be used in conjunction. (12 Dec 1998) |
| adjuvant therapy | <oncology, pharmacology> Treatment that is added to increase the effectiveness of a primary treatment. In cancer, adjuvant treatment usually refers to chemotherapy, hormonal therapy or radiation therapy after surgery to increase the likelihood of killing all cancer cells. (14 May 1997) |
| alternative therapy | A term given to nonconventional therapy usually given by persons who do not have a medical qualification. (16 Dec 1997) |
| analytic therapy | Short term for psychoanalytic therapy. (05 Mar 2000) |
| Antibody Directed Enzyme Prodrug Therapy | <pharmacology> A method for targeting a drug to a specific tissue, in which the targeting agent and the drug are administered separately. The drug is designed to be inactive (a prodrug) until it is converted by an enzyme, which is the targeting agent. The enzyme is coupled to an antibody that directs it to the tissue of interest. When the enzyme arrives at the tissue, the prodrug is activated only at that site, sparing other tissues from potentially toxic side effects. Acronym: ADEPT (14 Nov 1997) |
| anticoagulant therapy | The use of anticoagulant drugs to reduce or prevent intravascular or intracardiac clotting. (05 Mar 2000) |
| antisense therapy | Use of antisense DNA for the inhibition of translation of a specific gene product for therapeutic purposes. (05 Mar 2000) |
| art therapy | The use of art as an adjunctive therapy in the treatment of neurological, mental, or behavioural disorders. (12 Dec 1998) |
| autoserum therapy | Therapy with serum obtained from the patient's own blood. (05 Mar 2000) |
| aversion therapy | <psychology> A form of behaviour therapy that pairs an unpleasant stimulus with undesirable behaviour(s) so that the patient learns to avoid the latter. See: aversive training. (05 Mar 2000) |
| aversive therapy | <psychology> A treatment that suppresses undesirable behaviour by simultaneously exposing the subject to unpleasant consequences. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|